Startup Showcase: Cannaray – Revolutionizing Cannabis Wellness in Europe

2 mins read

If you thought cannabis was only for recreational purposes, think again. Cannaray, a leading European cannabis company, brings both medical THC and CBD wellness brands to the forefront. In this startup showcase, we’ll take a closer look at how Cannaray is revolutionizing cannabis wellness in Europe and changing the way we think about medical cannabis.

Introduction to Cannaray

Cannaray, located in London, England, is a company that offers two distinct cannabis brands. Cannaray CBD, the company’s flagship brand, offers a range of CBD wellness products including oils, capsules, gummies, and muscle balm. These products are designed to make CBD easy and accessible for millions of new people. Moreover, all Cannaray CBD products are formulated to be potent and enjoyable to use, triple-lab-tested for purity, and are packaged in vibrant, optimistic colors that will make you feel like anything is possible.

Cannaray Industries also offers a medical division known as Therismos, which imports and distributes cannabis-based products for medical use (CBPM) across Europe. By doing so, we strive to be the leading European full-service provider of medicinal cannabis through our innovative product solutions, valuable partnerships with strategic allies, and collaborating with world-class scientists and medical practitioners.

Cannaray CBD: Cannabis Wellness for Everyone

Cannaray CBD puts CBD wellness within reach of everyone, regardless of age or occupation. This brand is designed for people who want to enjoy a high-quality CBD experience and enjoy targeted benefits. Cannaray CBD’s product offering includes CBD Oil Drops for day and night, Capsules, Gummies, and Muscle Balm. Each product is carefully crafted to be effective and enjoyable, using the highest-quality ingredients available.

Read more from UKT News:  Can AI in Precision Oncology Revolutionise Early Cancer Diagnosis in the UK?

At Cannaray CBD, customers can shop with confidence. The company sources only lab-tested, non-GMO cannabis and extracts using the latest extraction techniques. Additionally, Cannaray CBD’s products are triple-lab-tested to ensure purity and safety.

Therismos: Medical Cannabis for Doctors and Patients

Therismos is the medical division of Cannaray and focuses exclusively on delivering reliable, high-quality CBPM products across Europe. The company is committed to improving patients’ quality of life by offering access to a vast range of CBPM products, operating transparently, providing valuable customer service, and collaborating with scientists and medical practitioners to optimize the delivery of cannabis-based medical therapies.

Through Therismos, Cannaray Industries is transforming the medical cannabis industry in Europe by working to ensure that therapeutic cannabis is easily accessible for patients while providing doctors with the tools they need to make informed prescribing decisions.

Cannaray’s Goals for the Future

Cannaray’s long-term goal is to be the leading European provider of cannabis-based products and therapies. The company continues to invest heavily in research and clinical trials to gain new knowledge and push the boundaries of the cannabis market further. Furthermore, Cannaray is committed to funding patient-led support groups and charities to provide support, resources and education to people living with specific medical conditions. Cannaray encourages and welcomes collaboration with scientists, practitioners and investors who share the company’s vision of providing safe, effective and affordable cannabis therapies for everyone in need.


Cannaray’s innovative approach to cannabis wellness and medicine is changing the way we think about cannabis in Europe. Through its flagship brand Cannaray CBD and its medical division Therismos, Cannaray is making cannabis more accessible and viable for people from all walks of life. With the mission to provide safe, high-quality cannabis-based products and therapies to improve patients’ quality of life and working to revolutionize the European cannabis market, Cannaray is on track to being one of the biggest players in the industry.

Read more from UKT News:  Which UK Startup Innovators are Transforming Innovation Management in 2023?

To learn more about Cannaray and their innovative cannabis products and therapies, visit their website or social media pages below.





Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.

Read more from UKT News:  Revolutionising Software Use with Centralised, Customisable Dashboards: The Future?

UKT News is a media platform owned by Unstructured Media, providing the latest news and insights on UK technology and startup scenes. The website offers readers with daily updates on the latest industry developments, as well as featuring exciting startups and advertising opportunities.

Leave a Reply

Your email address will not be published.